•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.APA (APA) Stock Drops Despite Market Gains: Important Facts to Note
APA Corporation provides second-quarter 2026 supplemental information and schedules results conference call for Aug. 6 at 10 a.m. Central time
APA Corporation Releases 2026 Sustainability Progress Report
Here's Why APA (APA) is a Strong Growth Stock
APA (APA) Suffers a Larger Drop Than the General Market: Key Insights
APA Corporation: Valuation Offers Growth At Bargain Levels
Zacks Industry Outlook APA , W&T and Ring
3 US E&P Stocks Backed by Rising 2026 Earnings Outlooks
APA Gains 63% in a Year: Is the Market Finally Catching On?
APA (APA) Stock Dips While Market Gains: Key Facts
Why APA (APA) is a Top Growth Stock for the Long-Term
APA Corporation: Suriname Is Getting Closer, And The Market Still Isn't Paying Attention
APA (APA) Stock Sinks As Market Gains: Here's Why
APA Expands Alaska Footprint With $70M Savant Acquisition Deal
APA Corporation Advances Alaska Position with Strategic Acquisition
APA (APA) Up 5.5% Since Last Earnings Report: Can It Continue?
APA or Ovintiv: Where Should Energy Investors Look Now?
Is APA's Suriname Portfolio the Market's Overlooked Gem?
Johnson & Johnson's Phase 3 prostate cancer study shows ERLEADA® (apalutamide) before and after surgery significantly reduces risk of metastasis or death, breaking a decades-long treatment paradigm
Here's Why APA (APA) is a Strong Growth Stock